Member Info for neilrich3

I'm don't think COVID revenue shall drop off from 2022, clearly the efficacy of the vaccine shall drop off, or wane, therefore testing both PCR and LFT antibody shall be just as important. Most experts seem to agree that we are facing a very difficult winter, personally can't see any change to the requirement for accurate testing going forward.

Poidster, SNPsig? Do you not mean Promate replacement for GENSIG?

The £19m provision that has already been made, as stated within the 2020 accounts, shall not affect the cash position.

Worth a watch for those that wish to learn more about testing for antibodies, both vaccine only induced immunity and antibodies for those who have been exposed to the virus. Not sure which companies have been involved with this study, however can see where Novacyt are going with their 2nd GEN LFT for antibodies.

FFWD 11 MINS
https://www.youtube.com/watch?v=TUMhItD3TkY

This chap appears to have been appointed August of last year, although only appeared upon Linkedin Today. An interesting background, an analyst at Woodford Investment Management and UBS Investment Bank.

https://www.linkedin.com/in/roy-bartel-taverner-53100464/?originalSubdomain=uk

Clearly so much going on behind the scenes, much of which we know nothing about.

I'd agree, only a matter of time before every GP Practice /Walk in centre has a Q16 on site. Not just for the purposes of COVID/FLU, but for the purposes of Antimicrobial Resistance (the number one threat to health).

Truimp1 wrote: Although saying confident regarding future growth, not confident enough to upgrade full year revenue ex-DHSC but only reiterate, which will leave H1 vs H2 growth flat?

The shall leave that for the new CEO, expect David Allmond to release an RNS mid November stating that NCYT shall smash the previous guidance!!

Have not been able to follow Today's events, have I missed anything? Have not got the time to trawl through 426 posts.

Careful....I got slated last night for suggesting that it might not be genuine!

I'm not convinced that it is genuine, in fact...hope it is not, not blown away, does not smack mid cap company.

The company website has been updated with new mug shots for some of the newer members of the Executive Management:
https://novacyt.com/executive-management/

Good to see that Guillermo is within the UK.

In my opinion the R&D update is long overdue, I'd guess that such items are now being saved for release in the run up to the AGM. There's has to be a number of good news items before the AGM, how else will the company be able to push through their resolutions.

Wilson, Thanks, my link did not work, however an interesting development and you'd think another excellent opportunity for the Q32/Q16 plus Promate.

https://www.thenationalnews.com/uae/2021/08/10/uae-flights-****stan-airlines-hope-rapid-pcr-tests-will-be-available-soon/

Wonder which members of the Executive Management shall be present to deliver the presentation and available for Q&A? I'd be interested to hear from Guillermo Raimondo and Anthony Dyer, hopefully Graham shall be there too with a few rabbits in his hat!!

Randox employs Conservative MP Owen Paterson as a consultant for £100,000 a year which easily surpasses his salary as an MP.

Paterson has previously lobbied the government on behalf of the company. Randox has insisted its relationship with Mr Paterson had no role in it winning the multimillion contract from the government.

What?!! Someone is suggesting that HM Government might abolish PCR in the middle of a Global pandemic due to one particular company which happens to be failing it customers.

Really?!

Temuchin, Check the date within the footer, published 8 Aug 2021.

This issue is not with those that manufacture the tests, the problem is the test providers, the 400+ companies that sell the tests directly to the consumers.

Soder, Don't disagree, however the ADR is a lengthy process with strict confidentiality. There shall come a point within the process where an announcement shall be appropriate and to which both parties consent, clearly we are not there yet, simply suggesting that perhaps both parties might have reached an agreement in principle, however still some work to do behind the scenes to finalise.